UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.08 +0.08 (+0.10%) GOLD FUTURES
2,315.80 +4.80 (+0.21%) DOW
38,256.86 +353.57 (+0.93%) Bitcoin GBP
47,270.35 +563.06 (+1.21%)
Travere Therapeutics, Inc. (17R.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 07:39PM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 1.04B |
| Enterprise value | 786.50M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.44 |
| Price/book (mrq) | 3.70 |
| Enterprise value/revenue | 3.71 |
| Enterprise value/EBITDA | -3.36 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.62 |
| 52-week change 3 | 6.79% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 26.40 |
| 52-week low 3 | 10.80 |
| 50-day moving average 3 | 12.15 |
| 200-day moving average 3 | 17.06 |
Share statistics
| Avg vol (3-month) 3 | 60 |
| Avg vol (10-day) 3 | 249 |
| Shares outstanding 5 | 60.72M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 60.55M |
| % held by insiders 1 | 0.65% |
| % held by institutions 1 | 115.25% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | N/A |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -76.70% |
| Operating margin (ttm) | -183.85% |
Management effectiveness
| Return on assets (ttm) | -32.22% |
| Return on equity (ttm) | -308.90% |
Income statement
| Revenue (ttm) | 145.24M |
| Revenue per share (ttm) | 1.96 |
| Quarterly revenue growth (yoy) | 53.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -338.21M |
| Net income avi to common (ttm) | -376.33M |
| Diluted EPS (ttm) | -3.12 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 566.85M |
| Total cash per share (mrq) | 7.45 |
| Total debt (mrq) | 404.78M |
| Total debt/equity (mrq) | 201.58% |
| Current ratio (mrq) | 3.47 |
| Book value per share (mrq) | 2.66 |
Cash flow statement
| Operating cash flow (ttm) | -280.02M |
| Levered free cash flow (ttm) | -178.78M |
© 2024 Yahoo. All rights reserved.